...
首页> 外文期刊>Internal medicine journal >Thalidomide in angiodysplasia-related bleeding
【24h】

Thalidomide in angiodysplasia-related bleeding

机译:沙利度胺治疗血管增生相关性出血

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Gastrointestinal haemorrhage from angiodysplastic lesions is not only difficult to identify, but often refractory to endoscopic intervention. Patients often require substantial transfusion support. Thalidomide has emerged as a promising medical strategy in angiodysplasia-related bleeding. We present our experience and report the findings from a review of the literature. Despite its side-effect profile, thalidomide remains the therapeutic modality with the best evidence in this difficult clinical scenario.
机译:血管增生性病变引起的胃肠道出血不仅难以识别,而且内镜干预通常难以治愈。患者通常需要大量的输血支持。沙利度胺已成为血管增生相关出血的一种有前途的医学策略。我们介绍我们的经验并报告从文献回顾中得出的结论。尽管沙利度胺有副作用,但在这种困难的临床情况下,沙利度胺仍然是具有最佳证据的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号